We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+15.73%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.4B
AUM Growth
+$1.02B
Cap. Flow
-$761M
Cap. Flow %
-6.65%
Top 10 Hldgs %
38.51%
Holding
1,217
New
80
Increased
450
Reduced
355
Closed
36

Top Buys

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$250M
2
EQIX icon
Equinix
EQIX
+$102M
3
EXR icon
Extra Space Storage
EXR
+$63.2M
4
INVH icon
Invitation Homes
INVH
+$48.9M
5
PEB icon
Pebblebrook Hotel Trust
PEB
+$41.9M

Top Sells

Rank Stock Value
1
VNO icon
Vornado Realty Trust
VNO
+$172M
2
CCI icon
Crown Castle
CCI
+$121M
3
DOC icon
Healthpeak Properties
DOC
+$101M
4
VTR icon
Ventas
VTR
+$100M
5
SBAC icon
SBA Communications
SBAC
+$96.7M

Sector Composition

Rank Sector Weight
1 Real Estate 74.34%
2 Technology 3.93%
3 Industrials 3.02%
4 Financials 2.65%
5 Healthcare 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
1051
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$6K ﹤0.01%
649
+182
+39% +$1.86K
TVTX icon
1052
Travere Therapeutics
TVTX
$5.3B
$6K ﹤0.01%
263
+46
+21% +$1.02K
URGN icon
1053
UroGen Pharma
URGN
$2.01B
$6K ﹤0.01%
+150
New +$6.29K
VNDA icon
1054
Vanda Pharmaceuticals
VNDA
$315M
$6K ﹤0.01%
335
+87
+35% +$1.98K
DCPH
1055
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$6K ﹤0.01%
240
-90
-27% -$2.36K
EPZM
1056
DELISTED
Epizyme, Inc
EPZM
$6K ﹤0.01%
504
+121
+32% +$1.35K
DRNA
1057
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$6K ﹤0.01%
399
-201
-34% -$2.31K
VER
1058
CALL
DELISTED
VEREIT, Inc.
VER
$6K ﹤0.01%
261
-59
-18% -$2.36K
RARX
1059
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$6K ﹤0.01%
267
+142
+114% +$3.05K
AMPH icon
1060
Amphastar Pharmaceuticals
AMPH
$847M
$5K ﹤0.01%
254
– –
ANIP icon
1061
ANI Pharmaceuticals
ANIP
$1.78B
$5K ﹤0.01%
64
– –
CERS icon
1062
Cerus
CERS
$621M
$5K ﹤0.01%
871
+241
+38% +$1.46K
OMER icon
1063
Omeros
OMER
$821M
$5K ﹤0.01%
265
– –
RCKT icon
1064
Rocket Pharmaceuticals
RCKT
$359M
$5K ﹤0.01%
276
-124
-31% -$1.96K
TVRD
1065
Tvardi Therapeutics
TVRD
$23.5M
$5K ﹤0.01%
7
+2
+40% +$1.2K
CBAY
1066
DELISTED
Cymabay Therapeutics
CBAY
$5K ﹤0.01%
378
-322
-46% -$3.42K
NSTG
1067
DELISTED
NanoString Technologies, Inc.
NSTG
$5K ﹤0.01%
196
+56
+40% +$1.29K
ATNX
1068
DELISTED
Athenex, Inc. Common Stock
ATNX
$5K ﹤0.01%
21
+5
+31% +$1.22K
RDUS
1069
DELISTED
Radius Health, Inc.
RDUS
$5K ﹤0.01%
246
– –
EIDX
1070
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$5K ﹤0.01%
234
-116
-33% -$1.86K
AUTL
1071
Autolus Therapeutics
AUTL
$394M
$4K ﹤0.01%
115
-85
-43% -$2.42K
DNTH icon
1072
Dianthus Therapeutics
DNTH
$5.75B
$4K ﹤0.01%
+14
New +$2.42K
EOLS icon
1073
Evolus
EOLS
$404M
$4K ﹤0.01%
173
-227
-57% -$4.91K
KURA icon
1074
Kura Oncology
KURA
$923M
$4K ﹤0.01%
242
+75
+45% +$1.16K
NTLA icon
1075
Intellia Therapeutics
NTLA
$1.51B
$4K ﹤0.01%
234
– –
41 42
43
44 45

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q1 2019 Portfolio in Review

As of Q1 2019, Daiwa Securities Group held 1,217 positions worth $11.4B, up 9.8% from $10.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group withdrew a net $761M in Q1 2019, closing 36 positions and reducing 355 holdings. Its most notable exit was CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 74% of assets, down from 75% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Steris worth $13.7M.

  • Daiwa Securities Group's largest Q1 2019 buy was Steris: 106,969 shares worth $13.7M.
  • Daiwa Securities Group added most to Public Storage in Q1 2019, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2019 reduction was Vornado Realty Trust, cutting an estimated $172M.
  • Daiwa Securities Group fully exited CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S in Q1 2019, selling an estimated $15.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $11.4B portfolio in Q1 2019.
  • Daiwa Securities Group opened 80 new positions and closed 36 in Q1 2019.
  • Daiwa Securities Group's portfolio value rose 9.8% quarter-over-quarter to $11.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2019, filed 26 Apr 2019.